Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 10 of 10 publications.

Ribera A, Gimenez E, Oristrell G, Osorio D, Marsal JR, Garcia-Perez L, Ballesteros M, Rodenas E, Belahnech Y, Escalona R, Rivas N, Roca-Luque I, Ferreira-Gonzalez I, Espallargues M. Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Rev Esp Cardiol (Engl Ed). 2022 Jan;75(1):12-21. doi: 10.1016/j.rec.2021.05.004

Dubner SJ, Teutsch C, Huisman MV, Diener H-C, Halperin J, Rothman KJ, Ma C-S, Chuquiure-Valenzuela E, Bergler-Klein J, Zint K, Franca LR, Lu S, Paquette M, Lip GYH. Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF. ESC Heart Fail. 2020 Oct;7(5):2679-89. doi: 10.1002/ehf2.12857

Galian-Gay L, Gordon B, Marsal JR, Rafecas A, Pijuan Domenech A, Castro MA, Subirana Domenech MT, Sureda C, Miranda B, Marti G, Garcia-Dorado D, Dos Subira L. Determinants of long-term outcome of repaired pulmonary valve stenosis. Rev Esp Cardiol (Engl Ed). 2020 Feb;73(2):131-8.

Oakes G, Soleas I, Woodward G, Ko D, Eberg M, Tu J, Khan A, Wang X, Gorzkiewicz V, Couris C, Medved W, Leeb K. Comparison of outcomes following coronary artery bypass graft surgery and percutaneous coronary intervention in Ontario as reported by the cardiac care network of Ontario and the Canadian Institute for Health Information. Poster presented at the Canadian Cardiovascular Congress 2017; October 21, 2017. Vancouver, British Columbia. [abstract] Can J Cardiol. 2017 Oct; 33(10 Suppl):S134-5. doi: 10.1016/j.cjca.2017.07.261

Tu JV, Khan AM, Ng K, Chu A. Recent temporal changes in atherosclerotic cardiovascular diseases in Ontario: clinical and health systems impact. Can J Cardiol. 2017 Mar;33(3):378-84. doi: 10.1016/j.cjca.2016.11.009

Sherrill EH, Halpern M, Khan SB, Zhang J, Panjabi S. Single Pill Versus Free-Equivalent Combination Therapies for Hypertension: a Meta-analysis of Health Care Costs and Adherence. J Clin Hypertens (Greenwich). 2011 Dec 5;13(12):898-909. doi: 10.1111/j.1751-7176.2011.00550.x

Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich). 2011 Dec 1;13(12):898-909.

Ribera A, Marsal JR, Ferreira-Gonzalez I, Cascant P, Pons JM, Mitjavila F, Salas T, Permanyer-Miralda G. Predicting in-hospital mortality with coronary bypass surgery using hospital discharge data: comparison with a prospective observational study. Rev Esp Cardiol (Engl Ed). 2008 Apr;61(8):843-52.

Serrano NC, Casas JP, Díaz LA, Páez C, Mesa CM, Cifuentes R, Monterrosa A, Bautista A, Hawe E, Hingorani AD, Vallance P, López-Jaramillo P. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. J Clin Hypertens (Greenwich). 2004;44(5):702-7.

Miller GJ, Li P, Jones A, Humphries SE, Montgomery HE, Payne JR, Dhamrait SS, Hawe E, Toor IS, Wootton PT, Luong L. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. J Clin Hypertens (Greenwich). 2003 Oct;42(4):500-6.